Zhejiang Jolly Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Jolly Pharmaceutical Co Ltd with three other
companies in this sector in China:
Beijing Beilu Pharmaceutical Company Limited
sales of 522.54 million Chinese Renmimbi [US$82.48 million]
of which 99%
was Pharmaceutical Sales),
Beijing Science Sun Pharmaceutical Co Ltd
(749.99 million Chinese Renmimbi [US$118.39 million]
of which 100%
was Phamaceutical Manufacturing Industry), and
Chengdu Taihe Health Technology Group Inc Ltd
(590.95 million Chinese Renmimbi [US$93.28 million]
of which 86%
was Medicine Manufacturing).
Zhejiang Jolly Pharmaceutical Co Ltd reported sales of 793.91 million Chinese Renmimbi (US$125.32 million)
December of 2017.
decrease of 5.5%
versus 2016, when the company's sales were 840.04 million Chinese Renmimbi.
Contributing to the drop in overall sales was the 11.4% decline
in Medicinal, from 670.32 million Chinese Renmimbi to 594.00 million Chinese Renmimbi.
However, these declines were partially offset by the increase in sales of
Medicine Circulation (up 16.9% to 197.63 million Chinese Renmimbi)
Other (up 268.4% to 2.28 million Chinese Renmimbi)